Catalyst Funds Management’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,700	Closed	-$15.1K	–	1358
2024 Q2	$15.1K	Buy	2,700 +2,400	+800%	+$13.4K	﹤0.01%	778
2024 Q1	$2.01K	Buy	+300	New	+$2.01K	﹤0.01%	1052